Oncosil Medical Ltd (OSL) — Capital Reinvestment Ratio
Latest as of June 2015:
0.07x
Oncosil Medical Ltd (OSL) has a Capital Reinvestment Ratio of 0.07x as of June 2015, meaning it reinvests 0% of its operating cash flow (AU$596.28K) in capital expenditures (AU$43.85K). See OSL free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.07x
Capex / Operating Cash Flow
Operating Cash Flow
AU$596.28K
AUD
Capital Expenditures
AU$43.85K
AUD
Data as of
Jun 2015
Most recent filing
Oncosil Medical Ltd Capital Reinvestment Ratio (2006–2010)
This chart tracks Oncosil Medical Ltd's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Oncosil Medical Ltd (2006–2010)
Year-by-year Capital Reinvestment Ratio for Oncosil Medical Ltd from 2006 to 2010. For live market cap and broader valuation context, see OSL stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.20x | AU$154.35K | AU$30.48K | ▼ -85.8% |
| 2006 | 1.39x | AU$195.51K | AU$271.11K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow